Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Survey highlights need for primary care guidance on NSAID use

10.06.2005


New guidance on NSAID (non-steroidal anti-inflammatory drug) use is urgently needed to ensure the best patient care, European experts said today. The news coincides with the results from a European survey of 626 arthritis patients which found that many are confused and worried about the potential side-effects of their medication.



Primary care physicians now face an increasingly limited range of prescribing options for long-term arthritis pain management, following the withdrawal of Vioxx (rofecoxib) and the suspension of Bextra (valdecoxib), and the safety restrictions on the use of remaining drugs in the COX-2 selective NSAID class.

All NSAIDs – which include aspirin and ibuprofen – carry a risk of distressing and sometimes fatal upper gastrointestinal (GI) side-effects. For example, each year in the UK NSAIDs cause approximately 3,500 hospitalisations for, and 400 deaths from, ulcer bleeding in patients aged 60 years and above.


Despite these well-known risks, more than 45 per cent (46.18 per cent) of those patients participating in the survey felt they had received little or no support on managing the side-effects of their treatment from their doctor. More than one in six patients with arthritis (17.8 per cent) were still unaware of potential drug side-effects.

Professor Greg Rubin, Chairman of the European Society for Primary Care Gastroenterology (ESPCG) and Professor of Primary Care at the University of Sunderland, UK, said: “These results confirm our current thinking, that there is a lot of conflicting information on the risks of NSAIDs, including COX-2 selective NSAIDs. This makes it more difficult for primary care physicians to weigh up the risks and benefits of each treatment option and thus to make the correct decision for each individual patient. The ESPCG is eager to develop guidance to support European primary care practitioners in this decision making process.”

A cost-effectiveness study recently found that the combination of a non-selective NSAID and a proton pump inhibitor (PPI) is a more cost-effective treatment option than a COX-2 selective NSAID alone in preventing ulcer complications for many arthritis patients, particularly those at high risk of a GI or cardiovascular adverse event.

Combining NSAID therapy with Nexium effectively resolves symptoms of heartburn and acid regurgitation, as well as preventing peptic and gastric ulcers in at-risk patients, and healing gastric ulcers associated with long-term use of NSAIDs, including COX-2 selective NSAIDs.

Results of the European survey also showed that 25 per cent of people with arthritis had been offered treatment to protect against the upper GI side-effects of their medication.

Lucy Hughes | alfa
Further information:
http://www.hillandknowlton.com

More articles from Health and Medicine:

nachricht Satellites, airport visibility readings shed light on troops' exposure to air pollution
09.12.2016 | Veterans Affairs Research Communications

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>